Scorpion Therapeutics Scores $108 Million Series A Funding for Oncological Research
By Eduardo Longoria On October 26th, Boston-based Scorpion Therapeutics, a just-hatched fledgling company, announced the closing of a $108 million Series A financing. The investment was led by Atlas Ventures, …
Read More